1. 输入关键词后点击检索按钮可查询指定关键词在语料中的对应情况
  2. 选择语种可限定关键词的语言,当前支持中文和英文,默认选择中文
  3. 主题选项中可限定检索语料的文章主题范围,默认全部主题
  4. 主题选项中可限定检索语料的文本类型范围,默认全部类型
  5. 在结果列表中,点击操作栏中的“查看中文全文”或“查看英文全文”按钮可查看该句所在的中文语料全文
句对齐列表 共 16269 个结果  
序号 中文 英文 操作
9241 这将使它们能够直接获得疫苗发展疫苗生产的本地生态系统 This will allow for both direct access to vaccines, as well as the development of local ecosystems of vaccine production.
9242 只要全球供应链不中断,就能让下一次危机中的供应更加可靠和公平。 It will make supply in the event of the next crisis more reliable and more equitable, as long as global supply chains are not interrupted.
9243 世界卫生组织(世卫组织)、非洲联盟、欧洲联盟以及南非、卢旺达、塞内加尔、德国和法国政府及伙伴正在努力帮助行业和合作伙伴扩大本地疫苗生产以及加强全球和区域合作,以预防和应对未来的大流行。 The World Health Organization (WHO), the African Union, the European Union, the Governments of South Africa, Rwanda, Senegal, Germany and France, and partners, are working to help industry and partners scale up local vaccine production and improve global and regional collaboration to prevent and respond to future pandemics.
9244 为确保世界所有区域拥有最先进的生产基础设施、训练有素的人员以及机构和监管安排进行集体投资是我们保证共同卫生安全的宝贵财富。 Investing collectively to ensure all regions of the world have state-of-the-art production infrastructure, trained personnel and institutional and regulatory arrangements is a valuable asset for our common health security.
9245 世卫组织正在支持开展多边合作,以便在发展中国家开发和传播mRNA技术 WHO is supporting a multilateral effort to create and spread mRNA technology in developing countries.
9246 一年前,在欧盟、法国、德国和其他本地和国际伙伴支持下,世卫组织、南非和药品专利池在开普敦设立了一个mRNA疫苗技术转让中心[1]。 One year ago, WHO, South Africa and the Medicines Patent Pool established a technology transfer hub for mRNA vaccines in Cape Town [1] , supported by EU, France, Germany and other local and international partners.
9247 中心目标是通过培训和许可疫苗生产企业生产供本国本区域使用的疫苗,以便将这项技术推广到发展中国家 The hub’s goal is to spread this technology to developing countries by training and licensing manufacturers to produce their own vaccines for national and regional use.
9248 在捐助者支持下,该中心已经取得了一些成果 With donor support, the hub is already producing results.
9249 科学家们已根据公开资料设计出一种新的mRNA疫苗 Scientists have designed a new mRNA vaccine based on publicly available information.
9250 并已选中一些非洲、拉丁美洲、亚洲和欧洲的本地疫苗生产企业来获得这项技术 Local manufacturers from Africa, Latin America, Asia and Europe have been selected to receive the technology.